| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
1,190,000 |
| Market
Cap: |
3.09(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.5846 - $15.75 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Avinger is a commercial-stage medical device company that designs, manufactures and sells real-time image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Co.'s proprieary image-guided Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion, and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
223 |
| Total Sell Value |
$0 |
$0 |
$0 |
$181 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Simpson John B Ph D Md |
Executive Chairman |
• • • |
2016-05-06 |
4 |
A |
$0.00 |
$0 |
I/I |
24,952 |
1,074,130 |
|
- |
|
| Patel Himanshu |
CTO |
• – – |
2016-05-06 |
4 |
S |
$13.40 |
$134,000 |
D/D |
(10,000) |
87,220 |
|
- |
|
| Simpson John B Ph D Md |
Executive Chairman |
• • • |
2016-04-15 |
4 |
AS |
$13.11 |
$984,525 |
I/I |
(75,111) |
1,049,178 |
|
- |
|
| Ferguson Matthew |
Chief Financial Officer |
• – – |
2016-03-11 |
4 |
B |
$11.30 |
$17,050 |
D/D |
1,500 |
18,754 |
0.01 |
- |
|
| Simpson John B Ph D Md |
Executive Chairman |
• • • |
2016-03-11 |
4 |
S |
$11.44 |
$457,528 |
I/I |
(40,000) |
1,124,289 |
|
- |
|
| Soinski Jeffrey M |
Chief Executive Officer |
• – – |
2016-03-07 |
4 |
A |
$12.96 |
$388,800 |
D/D |
30,000 |
30,000 |
|
- |
|
| Simpson John B Ph D Md |
Executive Chairman |
• • • |
2016-03-07 |
4 |
A |
$12.96 |
$388,800 |
D/D |
30,000 |
30,000 |
|
- |
|
| Patel Himanshu |
CTO |
• – – |
2016-03-03 |
4 |
A |
$12.99 |
$162,375 |
D/D |
12,500 |
12,500 |
|
- |
|
| Desai Arjun |
Chief Medical Officer |
• – – |
2016-03-03 |
4 |
A |
$12.99 |
$324,750 |
D/D |
25,000 |
25,000 |
|
- |
|
| Banerjee Sougata |
Senior VP of Operations |
• – – |
2016-03-03 |
4 |
A |
$12.99 |
$162,375 |
D/D |
12,500 |
12,500 |
|
- |
|
| Ferguson Matthew |
Chief Financial Officer |
• – – |
2016-03-03 |
4 |
A |
$12.99 |
$162,375 |
D/D |
12,500 |
12,500 |
|
- |
|
| Ferguson Matthew |
Chief Financial Officer |
• – – |
2016-03-01 |
4 |
A |
$12.57 |
$18,905 |
D/D |
1,504 |
17,254 |
|
- |
|
| Soinski Jeffrey M |
Chief Executive Officer |
• – – |
2016-03-01 |
4 |
A |
$12.57 |
$12,055 |
D/D |
959 |
2,245 |
|
- |
|
| Patel Himanshu |
CTO |
• – – |
2016-03-01 |
4 |
A |
$12.57 |
$11,740 |
D/D |
934 |
97,220 |
|
- |
|
| Lucas Donald A |
|
– • • |
2015-12-14 |
4 |
S |
$15.90 |
$40,555 |
I/I |
(2,500) |
9,309 |
|
- |
|
| Lucas Donald A |
|
– • • |
2015-12-14 |
4 |
S |
$15.87 |
$12,424 |
I/I |
(780) |
8 |
|
- |
|
| Lucas Donald A |
|
– • • |
2015-12-11 |
4 |
S |
$15.80 |
$63,680 |
I/I |
(4,000) |
11,809 |
|
- |
|
| Lucas Donald A |
|
– • • |
2015-12-09 |
4/A |
D |
$0.00 |
$0 |
I/I |
(561,250) |
788 |
|
- |
|
| Lucas Donald A |
|
– • • |
2015-12-09 |
4 |
A |
$15.99 |
$252,786 |
I/I |
15,809 |
15,809 |
|
- |
|
| Lucas Donald A |
|
– • • |
2015-12-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(562,038) |
0 |
|
- |
|
| Simpson John B Ph D Md |
Executive Chairman |
• • • |
2015-11-25 |
4 |
S |
$17.30 |
$995,575 |
I/I |
(57,555) |
1,164,289 |
|
- |
|
| Simpson John B Ph D Md |
Executive Chairman |
• • • |
2015-11-24 |
4 |
S |
$17.20 |
$730,181 |
I/I |
(42,445) |
1,221,844 |
|
- |
|
| Soinski Jeffrey M |
Chief Executive Officer |
• – – |
2015-09-01 |
4 |
A |
$11.05 |
$14,210 |
D/D |
1,286 |
1,286 |
|
- |
|
| Ferguson Matthew |
Chief Financial Officer |
• – – |
2015-09-01 |
4 |
A |
$11.05 |
$21,249 |
D/D |
1,923 |
15,750 |
|
- |
|
| Desai Arjun |
Chief Medical Officer |
• – – |
2015-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,028 |
1,386 |
|
- |
|
247 Records found
|
|
Page 9 of 10 |
|
|
0.23 (7.96%) 
